Publications | Lund University Publications

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Jendle%2C+J.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Jendle%2C+J.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2010
Mark Increased Pulse-Pressure And Systemic Inflammation For Risk Prediction Of Cardio-Vascular Disease During 40 Years Of Follow-Up In 96,000 Subjects; The Varmland Health Study, Sweden
Khalili, P. ; Lundin, F. ; Jendle, J. ; Jungner, I. and Nilsson, Peter ^LU (2010) 20th Annual Meeting of the European-Society-of-Hypertension In Journal of Hypertension 28. p.37-37
- Contribution to journal › Published meeting abstract
Mark Willingness to pay for health improvements associated with anti-diabetes treatments for people with type 2 diabetes
Jendle, J. ; Torffvit, Ole ^LU ; Ridderstråle, Martin ^LU ; Lammert, M. ; Ericsson, A. and Bogelund, M. (2010) In Current Medical Research and Opinion 26(4). p.917-923
- Contribution to journal › Article
Mark Total adiponectin does not predict cardiovascular events in middle-aged men in a prospective, long-term follow-up study
Khalili, P. ; Flyvbjerg, A. ; Frystyk, J. ; Lundin, F. ; Jendle, J. ; Engström, Gunnar ^LU and Nilsson, Peter ^LU (2010) In Diabetes & Metabolism 36(2). p.137-143
- Contribution to journal › Article
2009
Mark Patient willingness-to-pay for liraglutide and exenatide in Sweden based on head-to-head clinical trial results
Ridderstråle, Martin ^LU ; Torffvit, Ole ^LU ; Lammert, M. ; Nilsen, B. ; Bogelund, M. and Jendle, J. (2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52. p.1040-1040
- Contribution to journal › Published meeting abstract
Mark Swedish patients with type 2 diabetes show willingness-to-pay for health improvements including weight loss, reduction in hypoglycaemia and glycaemic control
Jendle, J. ; Torffvit, Ole ^LU ; Ridderstråle, Martin ^LU ; Lammert, M. ; Ericsson, A. and Bogelund, M. (2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52. p.1039-1039
- Contribution to journal › Published meeting abstract
2008
Mark Adiponectin is an independent marker of glucose metabolism: a cross-sectional study in 4013 middle-aged men based on detailed oral glucose tolerance testing
Khalili, P. ; Jendle, J. ; Lundin, F. ; Engström, Gunnar ^LU ; Frystyk, J. ; Flyvbjerg, A. and Nilsson, P. M. (2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.290-290
- Contribution to journal › Published meeting abstract
Mark The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat
Jendle, J. ; Nauck, M. A. ; Matthews, D. ; Frid, Anders ^LU ; Hermansen, K. ; During, M. ; Zdravkovic, M. ; Strauss, B. and Garber, A. (2008) 44th EASD Annual Meeting of the European Association for the Study of Diabetes In Diabetologia 51(S1). p.318-318
- Contribution to journal › Published meeting abstract
2001
Mark Pharmacokinetics of pulmonary insulin in healthy smokers and non-smokers
Jendle, J ; Himmelmann, A ; Mellen, A ; Wollmer, Per ^LU ; Petersen, A H and Dahl, U L (2001) In Diabetologia 44(Suppl. 1). p.213-213
- Contribution to journal › Article

your query:: Remove author: Jendle, J.